CC BY 4.0 · Aorta (Stamford) 2018; 06(03): 075-080
DOI: 10.1055/s-0038-1669417
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Aortic Dysfunction in Mitral Regurgitation Due to Floppy Mitral Valve/Mitral Valve Prolapse

Hatem Mowafy
1   Division of Cardiovascular Medicine, Department of Medicine, The Ohio State University, Columbus, Ohio
2   Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Scott Lilly
1   Division of Cardiovascular Medicine, Department of Medicine, The Ohio State University, Columbus, Ohio
,
David A. Orsinelli
1   Division of Cardiovascular Medicine, Department of Medicine, The Ohio State University, Columbus, Ohio
,
Gregory Rushing
3   Division of Cardiac Surgery, Department of Surgery, The Ohio State University, Columbus, Ohio
,
Juan Crestanello
3   Division of Cardiac Surgery, Department of Surgery, The Ohio State University, Columbus, Ohio
,
Konstantinos Dean Boudoulas
1   Division of Cardiovascular Medicine, Department of Medicine, The Ohio State University, Columbus, Ohio
› Author Affiliations
Funding None.
Further Information

Publication History

16 April 2017

12 June 2018

Publication Date:
12 September 2018 (online)

Abstract

Background Floppy mitral valve/mitral valve prolapse (FMV/MVP), a heritable disorder of connective tissue, often leads to mitral regurgitation (MR) and is the most common cause for mitral valve surgery in developed countries. Connective tissue disorders may affect aortic function, and a stiff aorta may increase the severity of MR. Aortic function, however, has not been studied in FMV/MVP with MR.

Methods A total of 17 patients (11 men, 6 women) with FMV/MVP and significant MR were compared with 20 controls matched for age and gender. Aortic diameters (AoD) were measured from left ventriculograms at 2 and 4 cm above the aortic valve. Aortic pressures were measured directly using fluid-filled catheters. Aortic distensibility was calculated using the formula: 2(systolic AoD—diastolic AoD)/(diastolic AoD x pulse pressure).

Results Aortic distensibility was significantly lower in FMV/MVP compared with control at 2 cm above the aortic valve (1.00 ± 0.19 versus 3.78 ± 1.10 10−3 mm Hg−1, respectively; p = 0.027) and 4 cm above the aortic valve (0.89 ± 0.16 versus 3.22 ± 0.19 10−3 mm Hg−1, respectively; p = 0.007). FMV/MVP patients had greater left ventricular (LV) end-systolic (88 ± 72 mL versus 35 ± 15 mL, p = 0.002) and end-diastolic (165 ± 89 mL versus 100 ± 41 mL, p = 0.005) volumes, and lower LV ejection fraction, compared with control (50 ± 12% versus 57 ± 6%, p = 0.034).

Conclusion Aortic distensibility is decreased (consistent with a stiff aorta) in patients with FMV/MVP and MR. A stiff aorta may increase the severity of MR. Thus, abnormal aortic function, which also deteriorates with age, may play an important role in the natural history of MR due to FMV/MVP.

 
  • References

  • 1 Boudoulas KD, Boudoulas H. Floppy mitral valve (FMV)/mitral valve prolapse (MVP) and the FMV/MVP syndrome: pathophysiologic mechanisms and pathogenesis of symptoms. Cardiology 2013; 126 (02) 69-80
  • 2 Boudoulas H, Wooley CF. , Eds. Mitral Valve: Floppy Mitral Valve, Mitral Valve Prolapse, Mitral Valvular Regurgitation, 2nd ed, revised. Armonk, NY: Futura; 2000
  • 3 Davies MJ, Moore BP, Braimbridge MV. The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J 1978; 40 (05) 468-481
  • 4 Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med 1982; 97 (06) 826-832
  • 5 Grau JB, Pirelli L, Yu PJ, Galloway AC, Ostrer H. The genetics of mitral valve prolapse. Clin Genet 2007; 72 (04) 288-295
  • 6 Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation 2014; 129 (21) 2158-2170
  • 7 Boudoulas KD, Boudoulas H. Floppy mitral valve and mitral valve prolapse: lack of precise definition (the Tower of Babel syndrome). Cardiology 2011; 118 (02) 93-96
  • 8 Boudoulas KD, Pitsis AA, Boudoulas H. Floppy mitral valve (FMV) - mitral valve prolapse (MVP) - mitral valvular regurgitation and FMV/MVP syndrome. Hellenic J Cardiol 2016; 57 (02) 73-85
  • 9 Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA 1989; 262 (04) 523-528
  • 10 Bowen J, Boudoulas H, Wooley CF. Cardiovascular disease of connective tissue origin. Am J Med 1987; 82 (03) 481-488
  • 11 Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med 1980; 92 (2 Pt 1): 171-178
  • 12 Hirata K, Triposkiadis F, Sparks E, Bowen J, Boudoulas H, Wooley CF. The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J 1992; 123 (03) 743-752
  • 13 Boudoulas KD, Vlachopoulos C, Raman SV. , et al. Aortic function: from the research laboratory to the clinic. Cardiology 2012; 121 (01) 31-42
  • 14 Stefanadis C, Stratos C, Vlachopoulos C. , et al. Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation 1995; 92 (08) 2210-2219
  • 15 Vlachopoulos C, Aznaouridis K, Stefanadis C, Boudoulas H. Aortic function: methods of evaluation. In: Boudoulas H, Stefanadis C. , eds. The Aorta: Structure, Function, Dysfunction, and Diseases. New York: Informa Healthcare; 2009: 41-59
  • 16 Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol 1987; 59 (15) 1300-1304
  • 17 King BD, Clark MA, Baba N, Kilman JW, Wooley CF. “Myxomatous” mitral valves: collagen dissolution as the primary defect. Circulation 1982; 66 (02) 288-296
  • 18 Baker PB, Bansal G, Boudoulas H, Kolibash AJ, Kilman J, Wooley CF. Floppy mitral valve chordae tendineae: histopathologic alterations. Hum Pathol 1988; 19 (05) 507-512
  • 19 Wooley CF, Baker PB, Kolibash AJ, Kilman JW, Sparks EA, Boudoulas H. The floppy, myxomatous mitral valve, mitral valve prolapse, and mitral regurgitation. Prog Cardiovasc Dis 1991; 33 (06) 397-433
  • 20 Carabello BA. The myocardium in mitral regurgitation: a tale of 2 ventricles. Circulation 2013; 127 (15) 1567-1568
  • 21 Öztürk C, Schueler R, Weber M. , et al. Sympathetic activity in patients with secondary symptomatic mitral regurgitation or end-stage systolic heart failure. JACC Cardiovasc Interv 2016; 9 (19) 2050-2057
  • 22 Heistad DD, Marcus ML, Martins JB. Effects of neural stimuli on blood flow through vasa vasorum in dogs. Circ Res 1979; 45 (05) 615-620
  • 23 Stefanadis CI, Karayannacos PE, Boudoulas HK. , et al. Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. Cardiovasc Res 1993; 27 (06) 951-956
  • 24 Stefanadis C, Vlachopoulos C, Karayannacos P. , et al. Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation 1995; 91 (10) 2669-2678
  • 25 Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 1983; 2 (04) 638-644
  • 26 Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine--cardiovascular process. Circulation 1980; 61 (06) 1200-1205
  • 27 Theofilogiannakos EK, Boudoulas KD, Gawronski BE. , et al. Floppy mitral valve/mitral valve prolapse syndrome: beta-adrenergic receptor polymorphism may contribute to the pathogenesis of symptoms. J Cardiol 2015; 65 (05) 434-438
  • 28 Learoyd BM, Taylor MG. Alterations with age in the viscoelastic properties of human arterial walls. Circ Res 1966; 18 (03) 278-292
  • 29 Laurent S, Cockcroft J, Van Bortel L. , et al; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27 (21) 2588-2605
  • 30 Vlachopoulos C, Alexopoulos N, Boudoulas H, Stefanadis C. Aging and aortic function. In Boudoulas H, Stefanadis C. , eds. The Aorta: Structure, Function, Dysfunction, and Diseases. New York: Informa Healthcare; 2009: 64-70
  • 31 Boudoulas H, Stefanadis C. The Aorta: Structure Function, Dysfunction and Diseases. New York: Informa Healthcare; 2009
  • 32 Boudoulas KD, Sparks EA, Rittgers SE, Wooley CF, Boudoulas H. Factors determining left atrial kinetic energy in patients with chronic mitral valve disease. Herz 2003; 28 (05) 437-444
  • 33 Boudoulas H, Wooley CF. Floppy mitral valve/mitral valve prolapse/mitral valvular regurgitation: effects on the circulation. J Cardiol 2001; 37 (Suppl. 01) 15-20
  • 34 Sutton-Tyrrell K, Najjar SS, Boudreau RM. , et al; Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111 (25) 3384-3390
  • 35 Willum-Hansen T, Staessen JA, Torp-Pedersen C. , et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113 (05) 664-670
  • 36 Boudoulas KD, Paraskevaidis IA, Boudoulas H, Triposkiadis FK. The left atrium: from the research laboratory to the clinic. Cardiology 2014; 129 (01) 1-17